Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review

Minimal Clinically Important Difference of the Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF) for Fatigue Worsening in Asian Breast Cancer Patients

(2018) Alexandre Chan et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Psychometric properties of the FACT-M questionnaire in patients with Merkel cell carcinoma

(2017) Murtuza Bharmal et al.   Health and Quality of Life Outcomes

Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases

(2017) Srinivas Raman et al.   QUALITY OF LIFE RESEARCH

Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review

(2016) Frédéric Fiteni et al.   BMC CANCER

Impact of the occurrence of a response shift on the determination of the minimal important difference in a health-related quality of life score over time

(2016) Ahmad Ousmen et al.   Health and Quality of Life Outcomes

Statistical Challenges in the Analysis of Health-Related Quality of Life in Cancer Clinical Trials

(2016) Franck Bonnetain et al.   JOURNAL OF CLINICAL ONCOLOGY

Minimal Clinically Important Difference in the Physical, Emotional, and Total Symptom Distress Scores of the Edmonton Symptom Assessment System

(2016) David Hui et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Minimal clinically important differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL modules in patients with bone metastases undergoing palliative radiotherapy

(2016) Srinivas Raman et al.   QUALITY OF LIFE RESEARCH

EQ-5D-derived health utilities and minimally important differences for chronic health conditions: 2011 Commonwealth Fund Survey of Sicker Adults in Canada

(2016) Kate Tsiplova et al.   QUALITY OF LIFE RESEARCH

Hemoglobin levels and quality of life in patients with symptomatic chemotherapy-induced anemia: the eAQUA study

(2016) Jean-Loup Mouysset et al.   Cancer Management and Research

Quality of patient-reported outcome reporting across cancer randomized controlled trials according to the CONSORT patient-reported outcome extension: A pooled analysis of 557 trials

(2015) Fabio Efficace et al.   CANCER

Inclusion of patient-reported outcome measures in registered clinical trials: Evidence from ClinicalTrials.gov (2007–2013)

(2015) E. Vodicka et al.   Contemporary Clinical Trials

Interpretation of the Swedish Self Evaluation of Communication Experiences after Laryngeal cancer: Cutoff levels and minimum clinically important differences

(2015) Lisa Tuomi et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Minimal clinically important differences in the EORTC QLQ-BN20 in patients with brain metastases

(2015) Erin Wong et al.   SUPPORTIVE CARE IN CANCER

The self-reported Physical Activity Scale for the Elderly (PASE) is a valid and clinically applicable measure in lung cancer

(2015) Catherine L Granger et al.   SUPPORTIVE CARE IN CANCER

Minimally Important Difference for the Expanded Prostate Cancer Index Composite Short Form

(2015) Ted A. Skolarus et al.   UROLOGY

Minimal important difference of the 6-minute walk distance in lung cancer

(2015) Catherine L Granger et al.   Chronic Respiratory Disease

Minimal Clinically Important Differences in Quality of Life Scores of Oral Cavity and Oropharynx Cancer Patients

(2014) Yoav Binenbaum et al.   ANNALS OF SURGICAL ONCOLOGY

Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: Cognitive function (FACT-Cog) in breast cancer patients

(2014) Yin Ting Cheung et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Minimal important differences in the EORTC QLQ-C15-PAL to determine meaningful change in palliative advanced cancer patients

(2013) Gillian Bedard et al.   Asia-Pacific Journal of Clinical Oncology

Minimal important differences in the EORTC QLQ-C30 in patients with advanced cancer

(2013) Gillian Bedard et al.   Asia-Pacific Journal of Clinical Oncology

Patient self-appraisal of change and minimal clinically important difference on the European organization for the research and treatment of cancer quality of life questionnaire core 30 before and during cancer therapy

(2013) Fanxing Hong et al.   BMC CANCER

Measurement properties of the Work Limitations Questionnaire were sufficient among cancer survivors

(2013) Sietske J. Tamminga et al.   QUALITY OF LIFE RESEARCH

Quality of life assessed with EQ-5D in patients undergoing glioma surgery: What is the responsiveness and minimal clinically important difference?

(2013) Lisa Millgård Sagberg et al.   QUALITY OF LIFE RESEARCH

Minimal clinically important differences in the brief pain inventory in patients with bone metastases

(2013) Karrie Wong et al.   SUPPORTIVE CARE IN CANCER

Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30

(2012) K. Cocks et al.   EUROPEAN JOURNAL OF CANCER

Comparison of Distribution- and Anchor-Based Approaches to Infer Changes in Health-Related Quality of Life of Prostate Cancer Survivors

(2012) Ravishankar Jayadevappa et al.   HEALTH SERVICES RESEARCH

Minimal Clinically Important Differences in the Edmonton Symptom Assessment System in Patients With Advanced Cancer

(2012) Gillian Bedard et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases

(2012) Liang Zeng et al.   SUPPORTIVE CARE IN CANCER

The minimal clinical important difference in the World Health Organization Quality of Life instrument—100

(2012) Brenda L. Den Oudsten et al.   SUPPORTIVE CARE IN CANCER

Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients

(2011) J. Maringwa et al.   ANNALS OF ONCOLOGY

Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients

(2011) Kathleen J. Yost et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Impact of response shift on longitudinal quality-of-life assessment in cancer clinical trials

(2011) Zeinab Hamidou et al.   Expert Review of Pharmacoeconomics & Outcomes Research

Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinoma

(2010) Franck Bonnetain et al.   EUROPEAN JOURNAL OF CANCER

Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma

(2010) Ann K Kvam et al.   Health and Quality of Life Outcomes

Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials

(2010) John T. Maringwa et al.   SUPPORTIVE CARE IN CANCER

A new approach to combining clinical relevance and statistical significance for evaluation of quality of life changes in the individual patient

(2009) G. Kemmler et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Determining the minimal clinically important difference criteria for the Multidimensional Fatigue Inventory in a radiotherapy population

(2009) Amanda Purcell et al.   SUPPORTIVE CARE IN CANCER

Evaluating Minimal Important Differences for the FACT-Melanoma Quality of Life Questionnaire

(2009) Robert L. Askew et al.   VALUE IN HEALTH

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

Measurement and interpretation of social distress using the social difficulties inventory (SDI)

(2008) Penny Wright et al.   EUROPEAN JOURNAL OF CANCER

Estimating Clinically Meaningful Changes for the Functional Assessment of Cancer Therapy—Prostate: Results from a Clinical Trial of Patients with Metastatic Hormone-Refractory Prostate Cancer

(2008) David Cella et al.   VALUE IN HEALTH

Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes

(2007) Dennis Revicki et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY